Sort
82,697 grants matching “vaccine development”
Boosting Flu Vaccination without Adjuvant Injection
$717,661Mei X Wu · Massachusetts General Hospital · R01 · FY2015 · AI
Human Monoclonal Antibodies for Bioterrorism Defense
$717,652Vaccinex, Inc. · R43 · FY2005 · AI
Rocky Mountain Spotted Fever Vaccine Development
$717,631Roman R. Ganta · University Of Missouri-Columbia · R01 · FY2025 · AI
Structural and functional definition of human astrovirus-receptor interactions
$717,595Megan T Baldridge · Washington University · R01 · FY2025 · AI
Diversity of TFH cells and DSA generation after kidney transplantation
$717,584Diana M Metes · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AI
Optimization of novel phenotypic screening hits for treatment of Malaria
$717,556Margaret A. Phillips · Ut Southwestern Medical Center · R01 · FY2025 · AI
Neoantigen Vaccination for Lynch Syndrome Immunoprevention
$717,507Steven Monroe Lipkin · Weill Medical Coll Of Cornell Univ · U01 · FY2019 · CA
OMICs to define impact of cocaine on immunity and HIV persistence in treated HIV infection
$717,500Rafick-Pierre Sekaly · Case Western Reserve University · R01 · FY2016 · DA
Single domain antibodies for diagnosis and treatment of synucleinopathies
$717,491Einar M Sigurdsson · New York University School Of Medicine · R56 · FY2023 · AG
Development of IMPDH-Targeted Drugs against Crytosporidium
$717,483Lizbeth K. Hedstrom · Brandeis University · U01 · FY2010 · AI
Biocontainment Research support services core
$717,476Farhang Alem · George Mason University · UC7 · FY2023 · AI
Neoantigen-specific T cell responses for Fibrolamellar Hepatocellular Carcinoma
$717,369Mark Yarchoan · Johns Hopkins University · R01 · FY2025 · CA
NONHUMAN PRIMATE CORE QUANT IRAL RNA LABORATORY FOR AIDS VACCINE R&D
$717,307Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2016 · AI
Advanced Development of Vaccines for Infectious Diseases
$717,224Ly Phan · Versatope Therapeutics, Inc. · N01 · FY2021 · AI
Influenza vaccines inducing broadly cross protective immunity
$717,148Sang-Moo Kang · Georgia State University · R01 · FY2018 · AI
Personalized Adoptive T-cell Therapy for AML
$717,103David E Avigan · Beth Israel Deaconess Medical Center · R01 · FY2022 · CA
Dissemination of the Cardiovascular Risk Service (CVRS Live)
$717,072Korey A Kennelty · University Of Iowa · R01 · FY2022 · HL
Antigen-Specific NK Cell Memory Against SIV and SIV Vaccines
$717,026Roger Keith Reeves · Beth Israel Deaconess Medical Center · R56 · FY2015 · AI
Structural Vaccinology and Design of Novel Imunogens for Malaria Vaccine Development
$716,999Daniel E Goldberg · Washington University · R01 · FY2021 · AI
Multivalent Tick-Microbe targeted Lyme disease vaccines
$716,967Utpal Pal · Univ Of Maryland, College Park · R01 · FY2022 · AI
Understanding the rectal mucosal effects of cross-sex hormone therapy among US and Thai transgender women
$716,966Colleen F Kelley · Emory University · R01 · FY2019 · AI
Mucosal immunity and heterologous protection induced by single-cycle SIV
$716,955Amitinder Kaur · Harvard Medical School · P01 · FY2011 · AI
Intestinal Disease-enterocyte toxin interaction
$716,947Wayne Lencer · Boston Children'S Hospital · R37 · FY2017 · DK
Intestinal Disease-enterocyte toxin interaction
$716,947Wayne Lencer · Boston Children'S Hospital · R37 · FY2020 · DK
Intestinal Disease-enterocyte toxin interaction
$716,947Wayne Lencer · Boston Children'S Hospital · R37 · FY2019 · DK